Rajiv Patni

Chief Development Officer, Ocera Therapeutics, Inc.

Companies

Septerna, Inc.Chief Medical Officer Sep 3, 2026 to now¹
BioXcel Therapeutics, Inc.Board member Jan 16, 2025 to now²
IRulya Therapeutics Inc.Board member Feb 15, 2024 to now³
REATA PHARMACEUTICALS INCEVP, Chief R&D Officer Jun 14, 2023 to Sep 26, 2023⁴
Adamas Pharmaceuticals (United States)Chief Medical Officer Jun 9, 2015 to Apr 10, 2019⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

REATA PHARMACEUTICALS INC0 shares⁶Sep 26, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 26, 2023Returned to company 45,000 shares of REATA PHARMACEUTICALS INC⁶
Jun 12, 2023Granted 45,000 shares of REATA PHARMACEUTICALS INC⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSepterna, Inc., Chief Medical Officer
2
SEC EDGARBioXcel Therapeutics, Inc., Board member
3
SEC EDGARIRulya Therapeutics Inc., Board member
4
SEC EDGARREATA PHARMACEUTICALS INC, EVP, Chief R&D Officer
5
SEC EDGARAdamas Pharmaceuticals (United States), Chief Medical Officer
6
SEC EDGARREATA PHARMACEUTICALS INC shares after the filing of Sep 26, 2023
7
SEC EDGARForm 4 filed Jun 14, 2023